123 related articles for article (PubMed ID: 37890508)
41. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
Yin D; Lu X
Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
[TBL] [Abstract][Full Text] [Related]
42. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
43. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
[TBL] [Abstract][Full Text] [Related]
45. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
[TBL] [Abstract][Full Text] [Related]
46. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
[TBL] [Abstract][Full Text] [Related]
47. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
48. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
Duan H; Li X; Chen Y; Wang Y; Li Z
Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
[TBL] [Abstract][Full Text] [Related]
49. LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis.
Liu S; Wang X; Zhang J; Liu Y; Li B
Turk J Gastroenterol; 2023 May; 34(5):497-507. PubMed ID: 36620931
[TBL] [Abstract][Full Text] [Related]
50. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.
Chen Y; Zhang X; An Y; Liu B; Lu M
Mol Cell Endocrinol; 2020 Mar; 503():110697. PubMed ID: 31891769
[TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
52. miRNA Profiling of Hungarian Regressive Wilms' Tumor Formalin-Fixed Paraffin-Embedded (FFPE) Samples by Quantitative Real-Time Polymerase Chain Reaction (RT-PCR).
Buglyó G; Magyar Z; Romicsné Görbe É; Bánusz R; Csóka M; Micsik T; Mezei M; Yani JAS; Varga P; Sápi Z; Nagy B
Med Sci Monit; 2021 Oct; 27():e932731. PubMed ID: 34608109
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
Kan L; Yang M; Zhang H
Biol Direct; 2023 Jul; 18(1):36. PubMed ID: 37403106
[TBL] [Abstract][Full Text] [Related]
54. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
55. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
[TBL] [Abstract][Full Text] [Related]
56. Dysregulation of non-coding RNAs in Wilms tumor.
Taheri M; Hussen BM; Abdullah SR; Ghafouri-Fard S; Jamali E; Shojaei S
Pathol Res Pract; 2023 Jun; 246():154523. PubMed ID: 37201386
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-215-5p Inhibits the Proliferation and Migration of Wilm's Tumor Cells by Targeting CRK.
Li W; Lingdi L; Xiqiang D; Jiheng L; Xin T; Qin H; Haisha L
Technol Cancer Res Treat; 2021; 20():15330338211036523. PubMed ID: 34384283
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
[TBL] [Abstract][Full Text] [Related]
59. LncRNA MEG3 inhibits the growth, invasion and migration of Wilms' tumor via Wnt/β-catenin pathway.
Teng GY; Wang YJ; Geng M; Jiang ZP
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9899-9907. PubMed ID: 33090393
[TBL] [Abstract][Full Text] [Related]
60. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
